Web NewDrugInformation.com

Aeroseb-dex Drug - Aeroseb-dex The trade name of the product as shown on the labeling. Dosage - AEROSOL; TOPICAL The product dosage form and route separated by a semi-colon. Active Ingredient(s) - Dexamethasone Multiple ingredients are in alphabetical order. Strength - 0.01% The potency of the active ingredient(s), Dexamethasone. May repeat for multiple part products. Applicant - ALLERGAN HERBERT The firm name holding legal responsibility for Aeroseb-dex. The firm name is condensed to a maximum twenty character unique string. New Drug Application (NDA) Number - 083296 The FDA assigned number to Aeroseb-dex. Format is nnnnnn. Product Number - 002 The FDA assigned number to identify Aeroseb-dex. Each strength is a separate product. May repeat for multiple part products. Format is nnn. Therapeutic Equivalence (TE) Code - The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products. Approval Date - Approved Prior to Jan 1, 1982 The date Aeroseb-dex was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982". Reference Listed Drug (RLD) - No The pioneer or innovator of Aeroseb-dex. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No. Type - DISCN The group or category of approved drugs Aeroseb-dex is in. Format is RX, OTC, DISCN. Applicant Full Name - Allergan Herbert Div Allergan Inc The full name of the firm holding legal responsibility for the new application of Aeroseb-dex. Aeroseb-dex Topicort 0.05% Ointment; Topical Topicort 0.25% Ointment; Topical Doca 5mg/ml Injectable; Injection Percorten 125mg Pellet; Implantation Percorten 25mg/ml Injectable; Injection Aeroseb-dex 0.01% Aerosol; Topical Desoximetasone 0.05% Gel; Topical Topicort 0.05% Gel; Topical Desoximetasone 0.25% Ointment; Topical Desoximetasone 0.25% Ointment; Topical NewDrugInformation